Works by Gunda, Aparna

Results: 6

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.
Published in:
Cancer Medicine, 2023, v. 12, n. 12, p. 13342, doi. 10.1002/cam4.6032
By:
- Eshwaraiah, Mallikarjuna Siraganahalli;
- Gunda, Aparna;
- Kanakasetty, Govind Babu;
- Bakre, Manjiri M.
Publication type:
Article
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.
Published in:
Cancer Medicine, 2020, v. 9, n. 21, p. 7810, doi. 10.1002/cam4.3495
By:
- Sengupta, Aditya K.;
- Gunda, Aparna;
- Malpani, Sukriti;
- Serkad, Chandra Prakash V.;
- Basavaraj, Chetana;
- Bapat, Ashok;
- Bakre, Manjiri M.
Publication type:
Article
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients.
Published in:
2019
By:
- Attuluri, Arun Kumar;
- Serkad, Chandra Prakash V.;
- Gunda, Aparna;
- Ramkumar, Charusheila;
- Basavaraj, Chetana;
- Buturovic, Ljubomir;
- Madhav, Lekshmi;
- Naidu, Nirupama;
- Krishnamurthy, Naveen;
- Prathima, R.;
- Kanaldekar, Suchita;
- Bakre, Manjiri M.
Publication type:
journal article
Recurrence patterns-analysis from a South Indian breast cancer patient cohort.
Published in:
Indian Journal of Cancer, 2024, v. 61, n. 3, p. 471, doi. 10.4103/ijc.IJC_561_20
By:
- Thumsi, Jayanti;
- Gunda, Aparna;
- Natraj, Mallika;
- Bakre, Manjiri M
Publication type:
Article
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.
Published in:
Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01643-2
By:
- Zhang, Xi;
- Gunda, Aparna;
- Kranenbarg, Elma Meershoek-Klein;
- Liefers, Gerrit-Jan;
- Savitha, Badada Ananthamurthy;
- Shrivastava, Payal;
- Serkad, Chandra Prakash Vijay Kumar;
- Kaur, Taranjot;
- Eshwaraiah, Mallikarjuna Siraganahalli;
- Tollenaar, Rob A. E. M.;
- van de Velde, Cornelis J. H.;
- Seynaeve, Caroline M. J.;
- Bakre, Manjiri;
- Kuppen, Peter J. K.
Publication type:
Article
A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.
Published in:
Breast Cancer Research & Treatment, 2022, v. 196, n. 2, p. 299, doi. 10.1007/s10549-022-06729-7
By:
- Gunda, Aparna;
- Eshwaraiah, Mallikarjuna S.;
- Gangappa, Kiran;
- Kaur, Taranjot;
- Bakre, Manjiri M.
Publication type:
Article

Works by Gunda, Aparna

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.

Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients.

Recurrence patterns-analysis from a South Indian breast cancer patient cohort.

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.